Metabolic syndrome and its components are associated with lengths of stay in a psychiatric hospital: Results from a Swiss psychiatric cohort and first-episode psychosis patients
Nermine Laaboub, Setareh Ranjbar, Séverine Crettol, Nicolas Ansermot, Frederik Vandenberghe, Carole Grandjean, Marianna Piras, Julien Elowe, Martin Preisig, Armin Von Gunten, Philippe Conus, Chin Bin Eap

TL;DR
This study found that metabolic issues like obesity and high blood sugar are linked to longer hospital stays for psychiatric patients in Switzerland.
Contribution
The study is the first to show that metabolic syndrome components affect psychiatric hospital length of stay, especially in first-episode psychosis patients.
Findings
Central obesity, hyperglycemia, and hypertriglyceridemia were associated with extended hospital stays.
Underweight and low HDL cholesterol were linked to shorter hospital stays.
In first-episode psychosis patients, hypertriglyceridemia and hypertension were associated with longer stays.
Abstract
Due to limited inpatient care resources and high healthcare expenditures, understanding factors that affect lengths of stay (LOS) is highly relevant. We aimed to investigate associations between metabolic disturbances and LOS in a psychiatric hospital and to identify other clinical and sociodemographic LOS predictors. Patients admitted to one of the units of the general psychiatric or psychogeriatric departments between January 1, 2007 and December 31, 2020, were included. Metabolic disturbances (i.e., the metabolic syndrome and its five components) were defined using the International Diabetes Federation definition. Cox frailty regression models with time-varying coefficients were used to investigate the association between metabolic disturbances and LOS. Hazard ratios (HR) >1 and HR < 1 indicated the relative likelihood of shorter and extended LOS, respectively. A total of 7,771…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSchizophrenia research and treatment · Diet and metabolism studies · Diabetes Management and Research
